Income Statement
REVELATION BIOSCIENCES, INC.
REVB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
9.07 | 7.98 | 8.66 | 10.86 | 3.09 | 0.15 |
|
Research & Development
|
4.06 | 3.55 | 4.15 | 5.38 | - | - |
|
Selling, General & Administrative
|
5.01 | 4.43 | 4.51 | 5.49 | 3.09 | 0.15 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-9.07 | -7.98 | -8.66 | -10.86 | -3.09 | -0.15 |
|
Non-Operating Income
|
0.16 | -7.06 | 8.54 | 0.03 | - | -0.01 |
|
Interest Income
|
- | - | - | - | 0.01 | 0.01 |
|
Interest Expense
|
- | - | - | - | 0.04 | - |
|
Other Non-Op Income / Expense
|
0.16 | -7.14 | 0.21 | 0.03 | 0.96 | 0.01 |
|
Income Before Tax
|
- | - | - | - | - | -0.14 |
|
Income Tax Expense
|
- | - | - | - | - | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-8.91 | -15.04 | -0.12 | -10.83 | -2.13 | -0.14 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-9.07 | -7.98 | -8.66 | -10.86 | -3.09 | -0.15 |
|
Earnings Per Share (Basic)
|
-23.95 | -87.68 | -0.53 | -20.09 | -1.17 | - |
|
Diluted EPS
|
-23.95 | -87.68 | -0.53 | -20.09 | - | - |
|
Weighted Average Shares
|
0.62 | 0.17 | 0.23 | 0.54 | 1.82 | - |
|
Diluted Weighted Avg Shares
|
0.62 | 0.17 | 0.23 | 0.54 | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - |